Publications

5173 Results

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors
S Chadid;X Song;J Schenk;B Gurel;MS Lucia;I Thompson, Jr.;M Neuhouser;P Goodman;H Parnes;S Lippman;W Nelson;A De Marzo;E Platz
Journal / Conference
Nutrition and Cancer 74(1):141-148
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID33511883
PMC
PMC8319215
Study Number(s)
SWOG-9217

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Authors
S Adams;M Othus;S Patel;K Miller;R Chugh;S Schuetze;M Chamberlin;B Haley;A Storniolo;K Cawley;M Reddy;S Anderson;C Zimmerman;A O'Dea;M Mirshahidi;J Ahnert;F Brescia;O Hahn;J Raymond;D Biggs;M Thompson;R Connolly;E Sharon;L Korde;R Gray;E Mayerson;M Plets;CD Blanke;YK Chae;R Kurzrock
Journal / Conference
Clinical Cancer Research, Jan 15;28(2):271-278
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34716198
PMC
PMC8776596
Study Number(s)
S1609

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Authors
H Arai;A Elliott;J Millstein;J Xiu;F-S Ou;F Innocenti;J Wang;F Battaglin;P Jayachandran;N Kawanishi;S Soni;W Zhang;D Sohal;R Goldberg;M Hall;A Scott;M Khushman;J Hwang;E Lou;B Weinberg;A Lockhart;A Shields;J Abraham;D Magee;P Stafford;J Zhang;A Venook;A Venook;W Korn;H-J Lenz
Journal / Conference
Oncogene Jan;41(2):260-267
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID34728807
PMC
PMC8738154
Study Number(s)
CTSU/C80405

Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Authors
C Chau;C Till;D Price;P Goodman;M Neuhouser;M Pollak;I Thompson;W Figg
Journal / Conference
Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID34889205
PMC
PMC8776589
Study Number(s)
SWOG-9217

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Authors
V Shankaran;J Unger;A Darke;J Suga;J Wade;P Kourlas;S Chandana;M O'Rourke;S Satti;D Liggett;D Hershman;S Ramsey
Journal / Conference
Journal of the National Cancer Institute Mar 8;114(3):372-380; Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
Year
2022
Research Committee(s)
Cancer Care Delivery
PMID
PMID34981117
PMC
PMC8902339
Study Number(s)
S1417CD

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

Authors
B Darst;R Hughley;A Pfennig;U Hazra;C Fan;P Wan;X Sheng;E Klein;P Goodman;I Thompson;T Rebbeck;D Conti;C Haiman
Journal / Conference
European Urology Jan 11;S0302-2838(21)02271-5. doi: 10.1016/j.eururo.2021.12.023. Online ahead of print
Year
2022
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID35031163
Study Number(s)
S0000, SWOG-9217

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922

Authors
M Overman;K Guthrie;M Salem;K Pedersen;A Kalyan;S Bellasea;P Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S1922

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104

Authors
H Soares;K Guthrie;S Ahmad;M Washington;B Ramnaraign;N Raj;C Seigel;S Bellasea;E Chiorean;A Dasari;J Strosberg;C Eng;PA Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S2104

Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation

Authors
J Xu;K Guertin;N Gaddis;A Agler;R Parker;J Feldman;A Kristal;K Arnold;P Goodman;C Tangen;D Hancock;P Cassano
Journal / Conference
American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
Year
2022
Research Committee(s)
Prevention and Epidemiology
PMID
PMID35040869
Study Number(s)
S0000C